IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Column Group LLC

Q3 2025 Holdings

Filed 2025-11-14 | 5 holdings | $81.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Oric Pharmaceuticals Inc.(ORIC)COM68622P109$42.5M3,540,77752.5%
Surrozen, Inc.COM86889P109$19.3M1,499,77323.9%
Tenaya Therapeutics, Inc.(TNYA)COM87990A106$14.9M9,400,29018.3%
Rapt Therapeutics Inc(RAPTEUR)COM75382E109$4.3M166,0755.3%
Revolution Medicines Inc(RVMD)COM76155X100$2.1K460.0%